Mark L. Bagarazzi
2017
In 2017, Mark L. Bagarazzi earned a total compensation of $1.4M as Chief Medical Officer at Inovio Pharmaceuticals, a 4% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $148,750 |
|---|---|
| Option Awards | $437,586 |
| Salary | $435,053 |
| Stock Awards | $409,484 |
| Other | $13,846 |
| Total | $1,444,719 |
Bagarazzi received $437.6K in option awards, accounting for 30% of the total pay in 2017.
Bagarazzi also received $148.8K in non-equity incentive plan, $435.1K in salary, $409.5K in stock awards and $13.8K in other compensation.
Rankings
In 2017, Mark L. Bagarazzi's compensation ranked 7,188th out of 14,666 executives tracked by ExecPay. In other words, Bagarazzi earned more than 51.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,188 out of 14,666 | 51st |
Division Manufacturing | 2,672 out of 5,772 | 54th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 345 out of 859 | 60th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 175 out of 531 | 67th |
Industry Surgical and Medical Instruments and Apparatus | 107 out of 336 | 68th |
Source: SEC filing on March 28, 2018.
Bagarazzi's colleagues
We found three more compensation records of executives who worked with Mark L. Bagarazzi at Inovio Pharmaceuticals in 2017.